Physician profile
Azra Abbasi
NPI 1871196014
$1,372.83
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,062 · 2022: $264 · 2023: $47.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $47.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $47.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $192.95 | 2021-2022 | |
| Abbvie INC. | $164.65 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $149.29 | 2021-2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $134.04 | 2021 | |
| Novo Nordisk INC | $128.57 | 2021-2022 | |
| Amgen INC. | $73.77 | 2021-2023 | Otezla, Repatha |
| Takeda Pharmaceuticals U.S.A., INC. | $70.46 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $65.42 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.88 | 2021-2022 | |
| Dexcom, INC. | $49.26 | 2021 | |
| Glaxosmithkline, LLC. | $48.69 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $39.35 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $35.76 | 2021 | |
| Pfizer INC. | $33.68 | 2021 | |
| Merck Sharp & Dohme LLC | $30.38 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $28.69 | 2021 | |
| Amarin Pharma, INC. | $20.98 | 2021 | |
| Janssen Pharmaceuticals, INC | $20.03 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.34 | 2022 | |
| Ibsa Pharma INC. | $12.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Azra Abbasi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.